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T
his review was conducted to exam-
ine disordered eating behavior
(DEB), including diagnosable eating
disorders, in the context of diabetes. The
use of criteria and assessment methods
standardized on the healthy population is
examined. Also considered is the need for
modiﬁed assessment methods and classi-
ﬁcation of this behavior when evaluating
patients with diabetes. Future directions
for research are suggested.
Literature published from 1980 to
present was examined using “eating dis-
orders and diabetes” as search terms.
Over 100 peer-reviewed articles were
identiﬁed via PubMed, Cochrane Re-
views, PsycInfo, etc. Bibliographies from
articles were reviewed to ascertain addi-
tional publications. Cited articles include
reviews and individual studies indicating
experimental design (self as control,
healthy control, or population estimate),
assessment methods (self-report, ques-
tionnaires, and structured/clinical inter-
views), and use of standard diagnostic
criteria. Not all relevant articles could be
included. However, some older refer-
ences (published before 2000) are in-
cluded because they provide foundation
literature from which our understanding
of DEB in the population of patients with
diabetes derives and/or are validation
studies for measurement methods. Addi-
tional references pertinent to hypothe-
sized mechanisms are cited.
Most studies, including those in a
2005 meta-analysis (N  8 case-
controlled studies), tend to focus on
young women with type 1 diabetes, usu-
ally between ages 15–35 years, when
weight concerns, DEB, and eating disor-
ders are at a high prevalence (1). Recent
studies have included type 2 diabetic pa-
tients, minorities, and male patients (2–
9). The diagnosis of diabetes has been
associated with elevated rates of DEB and
eating disorders, particularly when insu-
lin omission is considered purging
(1,8–11).
Diagnosed eating disorders and sub-
clinical DEB have been associated with
poorer health in individuals with type 1 di-
abetes. Early reports found prevalence rates
oftheco-occurrenceofdiabetesandDEBto
be low and accompanied by psychiatric co-
morbidity and weight loss, but diabetes
control was not compromised (12–14).
More recent cross-sectional studies have
demonstrated a positive association be-
tween elevated A1C and diagnosable eating
disorders (2), subclinical DEB (8), and in-
tentionalinsulinomission(1).Thepresence
of diagnosable eating disorders and behav-
ior categorized as subclinical DEB has been
associated with increases in retinopathy
(15), neuropathy (16), transient lipid ab-
normalities (17), hospitalizations for dia-
betic ketoacidosis (6), and poor short-term
metabolic control (1,6,8,18). Studies as-
sessing the association of DEB and eating
disorders with long-term metabolic control
have produced mixed results (6,19–22). A
prospective 5-year study did not ﬁnd a sig-
niﬁcantrelationshipbetweenDEBoreating
disordersandpoorerglycemiccontrol(22).
Less is known about the relationships be-
tween DEB and health status in individuals
with type 2 diabetes (4,7,9).
PREVALENCE OF
DIAGNOSABLE EATING
DISORDERS AND DEB
IN PATIENTS
WITH DIABETES— Controversyexists
regarding whether there is increased
prevalence of diagnosable eating disor-
ders and DEB in individuals with type 1
diabetes than referent populations
(1,8,19).Ratessimilarto(1,8,23–25)and
higher than (1,6,23,24,26) healthy same-
aged peers (19,27) have been found.
Some studies found equivalent or lower
rates of diagnosable eating disorders but
higher rates of DEB, particularly bulimia
symptoms. Estimates of diagnosable eat-
ing disorders and DEB in adolescent and
young adult females with type 1 diabetes
range from 3.8% (12)–27.5% for patients
classiﬁed as bulimic or having binge
eating disorder (BED), based upon eval-
uation with the Eating Disorders Exam-
ination (EDE), (28) and 38–40%when
insulin omission is considered purging
(21,29). Individuals on insulin therapy
may ﬁnd insulin omission or dose reduc-
tion an easy method for weight manage-
ment via glycosuria. This method is
frequently reported by adolescent and
young adult females with type 1 diabetes
(2,29,30). Rates of both subclinical DEB
and diagnosable eating disorders are vari-
able based on the criteria used.
When establishing the relative preva-
lence of DEB in the diabetic population,
most studies have not matched control
samples for weight (1,19,21,26). Weight
status is a strong predictor of eating dis-
orders and DEB among overweight
womenattemptingweightloss(31).Type
1 diabetic cohorts studied have been sig-
niﬁcantly heavier than comparison
groups, with the average BMI above the
normal range (1,19). To compare an age-
and sex- (but not BMI-) matched control
sample to one with type 1 diabetic pa-
tients, the EDE (32) was administered.
Similar rates of eating pathology were
identiﬁed. However, using the Diagnostic
and Statistical Manual of Mental Disor-
ders,4thedition(DSM-IV)criteria,which
include insulin omission (33), higher
rates were identiﬁed in the diabetic sam-
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0.05) in the cohort with diabetes, and
higher BMI was associated with diagnos-
able eating disorders (26). In the 5-year
follow-upstudyoftype1diabeticpatients
(22), BMI was the strongest predictor of
eating disorders. Mannuci et al. (5) com-
pared overweight and obese type 2 dia-
betic patients with obese nondiabetic
patientsseekingweightloss,andanobese
non–treatment seeking sample. Among
all three samples, low levels of BED were
diagnosed (5%). Obese diabetic pa-
tients had the lowest scores on the EDE
overall but the highest Restraint Scale
scores (5). Only one study was found that
stratiﬁedthediabetescohort(type1and2
diabetic, male and female, ages 18–65
years) by weight status; 3% of under- and
normal-weight women had a current eat-
ing disorder, whereas 7% of overweight
and 10% of obese women had diagnos-
able eating disorders (27). These rates are
similar to those for nondiabetic samples
with similar BMI levels seeking weight
loss (31).
Subclinical DEB using DSM-IV Text
Revision (TR) (33) criteria such as binge
eating, self-induced vomiting, insulin
omission, excessive caloric restriction,
andintenseexerciseforweightcontrolare
commonly reported by female patients
withtype1diabetes(22,23).Inthe5-year
prospective study by Colton et al. (22),
patientsreportingsubclinicalDEBranged
from 3–26% depending on the behavior.
Fifty-one percent of the teens assessed
multiple times over a 5-year period re-
ported DEB at least once, and early sub-
clinical DEB was found to be highly
persistent over time. Rates documented
for male patients are lower but appear to
be changing. Svensson et al. (34) studied
adolescent males with type 1 diabetes
compared with healthy control subjects
and found no diagnosable eating disor-
ders in either group. Males with type 1
diabetes had signiﬁcantly higher BMIs
andscoresontheDriveforThinnessScale
on the Eating Disorder Inventory (EDI),
suggesting higher risk for the develop-
ment of DEB. Bulimia scores were, how-
ever, higher in control subjects than in
patients with diabetes (34). Studies using
questionnaires and structured interviews
that compare occurrence in type 1 versus
type2diabeticpatientsshowsimilarrates
(9,35).However,typesofreportedcogni-
tionsandbehaviorsdiffer.“Driveforthin-
ness” and “body dissatisfaction” were
more often reported by type 2 diabetic
patients, whereas insulin omission was
more frequently reported by type 1 dia-
betic patients (9,35).
INSULIN AND WEIGHT
GAIN— As glycemic control improves,
weight gain is a common side effect of
successful treatment with insulin (36).
Weight concerns may develop when in-
tensive treatment results in weight gain as
well as improved metabolic control
(1,6,8,37). Increasing weight can require
increasing doses of insulin or secreta-
goguetreatmenttocontrolbloodglucose,
which can lead to increased hunger, hy-
poglycemia, and dietary intake (38).
Comparing rates of DEB between type 1
diabetic adolescent females and healthy
control subjects, using both question-
naire and interview data, type 1 diabetic
femalesweresigniﬁcantlyheavier(6.8kg)
and had higher rates of DEB (19). Eng-
ström et al. suggest that eating more
might be a response to overinsulinization
and episodes of hypoglycemia because
both“stronglyactivateappetiteregulation
in the hypothalamus” (19). The evalua-
tionofsupraphysiologicallevelsofinsulin
as contributing to overeating and insulin
reduction as a compensatory strategy to
reduce appetite has not been explored.
Compared with injections, insulin pump
therapy can provide more physiological
insulin dosing and lower the need for in-
sulin (37,39). To compare rates of DEB
and attitudes between adolescent girls
with type 1 diabetes using pumps versus
injections, assessments included the
Drive for Thinness Scale, Bulimia and
Body Dissatisfaction subscales of the
EDI-2, the Dietary Restraint subscale of
the Eating Attitudes Test (EAT-26) (40),
and questions regarding efforts to control
weight by taking less insulin than pre-
scribed.Therewerenodifferencesinrates
of DEB or attitudes between adolescent
girls with type 1 diabetes who were using
insulin pumps and those using multiple
daily injections. Average BMI was within
normallimitsforbothgroupsanddidnot
predict DEB (37). However, insulin dose
per kilogram body weight, which is often
up to 15% lower in pump users than
those using injections (37,39), was not
evaluated as a possible contributor to
weight, satiety, overeating, or insulin
omission.
DYSREGULATION OF
SATIETY— Destructionof-cellsresults
in the inability to secrete both insulin and
amylin, contributing to dysregulation of
appetiteandsatiety.Amylinmediatessev-
eral satiety mechanisms via its effects on
the area postrema, an area of the brain-
stem that integrates hormonal and meta-
bolic signals to regulate food intake.
Acute anorectic effects of amylin include
slowed gastric emptying, reduced gluca-
gon secretion, and lateral hypothalamic
activity. Amylin is also thought to play a
role in long-term weight regulation
(41,42). Amylin, insulin, leptin, and glu-
cagon act synergistically with cholecysto-
kinin to reduce appetite (42). These
actions are opposed by ghrelin, concen-
trations of which are lower in obese and
type 2 diabetic patients and higher than
would be expected in patients with an-
orexia nervosa and type 1 diabetes
(42,43). Amylin analogs and other hor-
mones affecting the gut-brain axis are
considered potential therapies for condi-
tions related to obesity and DEB (44).
Pramlintide, an analog of amylin, en-
hances feelings of satiety, reducing food
intake and causing weight loss in patients
with diabetes (45).
In a study of other hormonal satiety
mechanisms in lean and obese nondia-
betic men, levels of postprandial insulin
and glucose-dependent insulinotropic
polypeptide (GIP) were found to be key
determinantsofshort-termappetiteregu-
lation (46). Miglitol, a second generation
-glucosidase inhibitor, was tested to
evaluate its effect on glucagon-like pep-
tide I (GLP-1) GIP, insulin-glucose dy-
namics, and satiety in obese type 2
diabetic women. After a solid meal chal-
lenge, type 2 diabetic women taking
miglitol had increased GLP-1 response,
suppressedGIP,increasedsatiety,andde-
creased hunger and food intake versus
those taking placebo (47). A review of
studies of incretins in type 1 diabetic pa-
tients during the remission phase of the
disease suggested that the use of long-
acting GLP-1 agonists, which modulate
insulin dynamics, could help patients
stick to their dietary program and main-
tain a normal between-meal interval (48).
No studies were identiﬁed that assessed
DEBinthecontextofphysiologicalmech-
anisms that are known to be associated
with dysregulation of appetite and satiety
and/or potentiate weight gain.
The current DSM-IV-TR deﬁnition of
DEB does not address hormonal alter-
ationsduetodiabetespathophysiologyor
treatment that may affect eating behav-
iors. The DSM-IV-TR classiﬁcation sys-
tem for DEB deﬁnes binging as a loss of
control over behavior and insulin omis-
sion as a maladaptive strategy to either
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glycosuria without an accompanying
binge.DSM-IV-TRcriteriastate:“Individ-
uals with diabetes and bulimia nervosa
may omit or reduce insulin doses to re-
duce the metabolism of food consumed
during eating binges” (33). Reﬁnement of
criteria to include the effects of treatment
has been suggested by the working group
convened during the International Con-
ference on Eating Disorders and Diabetes
Mellitus, which met in Minneapolis, Min-
nesota, in 2008 (49). Consideration of
physiological mechanisms that affect ap-
petite and satiety in the assessment of
DEB in patients with diabetes may also be
clinically relevant.
CLASSIFICATION:
ADHERENCE
NONCOMPLIANCE, OR
DISTRESS— Behaviors considered
triggersandconsequencesofDEBareem-
beddedinthediabetestreatmentregimen
(49). Behaviors and attitudes such as di-
etary restraint, food preoccupation (car-
bohydrate monitoring and restriction,
portioncontrol,andcontrolofbloodsug-
ars through selective food intake), and
programmed exercise are prescribed
components of diabetes care (39,50).
These same behaviors, excepting control
of blood glucose, characterize successful
weight loss treatment (51). Behaviors be-
come dysfunctional, DEB or eating disor-
ders, when they are used inappropriately
forrapidweightloss,arecarriedtoexcess,
interfere with activities of daily living, or
become a health risk (33). However, in
the context of diabetes care, strict adher-
ence to these behaviors provides tools by
which glycemic control may be achieved
(39). Thus, endorsement of items on
screening measures such as the EAT-26,
EDI-III, and Diagnostic Survey for Eating
Disorders (52) indicating food preoccu-
pation and restriction could initially be
identiﬁed as DEB in patients with diabe-
tes.Whenusingmeasuresstandardizedin
the general population, clinical evalua-
tion by an individual familiar with the di-
abetesself-careregimenmaybeneededto
further elucidate the intent and relation-
ships between endorsed behaviors and
weight concerns.
Feelingoutofcontroloffoodintakeis
a DSM-IV-TR diagnostic criterion for bu-
limia, BED, and EDNOS (see Table 1:
DSM-IV-TR criteria) (33). Attempts to
followaprescribeddietaryplanhavebeen
documented to result in patients experi-
encing loss of control of eating behavior
(53). The essential criterion for BED is re-
peatedlyeatingamountsoffoodinashort
period of time that are “larger than most
individuals would eat under similar cir-
cumstances.”BecauseDEBisrarelyquan-
tiﬁed by direct observation, this criterion
is usually self-reported. The determina-
tion of an objective versus a subjective
binge is an established challenge in the
evaluationofeatingdisorders.Illustrating
the relationship between report of food
intake, weight status, and diabetes, a
study of black women with type 2 dia-
betes found the prevalence of underre-
porting of dietary intake to be 47%.
Underreporting of intake was signiﬁ-
cantly associated with BMI and waist cir-
cumference in the expected direction:
Table 1—Adapted from the DSM-IV-TR: necessary diagnostic criteria for eating disorders
(axis-1)
Anorexia nervosa: rare in individuals with diabetes.
Refusal to maintain body weight at or above a minimally normal weight for age and height
(e.g., weight loss leading to maintenance of body weight 85% of that expected or
failure to make expected weight gain during period of growth, leading to body
weight 85% of that expected).
Intense fear of gaining weight or becoming fat, despite being underweight.
Disturbance in the way in which one’s body weight or shape is experienced, undue
inﬂuence of body weight or shape on self-evaluation, or denial of seriousness of the
current low body weight.
Bulimia nervosa: low prevalence rate of diagnosis but commonly reported behavior in
individuals with diabetes.
Recurrent episodes of binge eating, characterized by:
Eating, in a discrete period of time (e.g., within any 2-h period), an amount of food that
is deﬁnitely larger than most people would eat during a similar period of time and
under similar circumstances.
A sense of lack of control over eating during the episode (e.g., a feeling that one cannot
stop eating or control what or how much one is eating).
Recurrent inappropriate compensatory behavior in order to prevent weight gain, such as
self-induced vomiting; misuse of laxatives, diuretics, enemas, or other medications
(insulin omission); and fasting or excessive exercise.
Binge eating and inappropriate compensatory behaviors both occur, on average, 2
episodes per week for 3 months.
Self-evaluation is unduly inﬂuenced by body shape and weight concerns.
Eating disorder not otherwise speciﬁed (EDNOS): more commonly diagnosed in individuals
with diabetes and includes disorders of eating that do not meet the criteria for any
speciﬁc eating disorder.
All of the criteria for bulimia nervosa are met except that the binge eating and inappropriate
compensatory mechanisms occur at a frequency of 2 episodes per week or for
duration 3 months.
The regular use of inappropriate compensatory behavior by an individual of normal body
weight after eating small amounts of food (e.g., self-induced vomiting after the
consumption of two cookies or insulin omission or reduction after consumption of
normal amount of food).
Binge eating disorder (BED): most prevalent diagnosis in individuals with diabetes.
Recurrent episodes of binge eating. An episode is characterized by eating a larger amount of
food than normal during a short period of time (within any 2-h period) and lack of
control over eating during the binge episode (i.e., the feeling that one cannot stop
eating).
Binge eating episodes are associated with three or more of the following:
Eating until feeling uncomfortably full.
Eating large amounts of food when not physically hungry.
Eating much more rapidly than normal.
Eating alone because you are embarrassed by how much you are eating.
Feeling disgusted, depressed, or guilty after overeating.
Marked distress regarding binge eating is present.
Binge eating occurs, on average, 2 days per week for 6 months.
The binge eating is not associated with the regular use of inappropriate compensatory
behavior (i.e., purging, excessive exercise, etc.) and does not occur exclusively
during the course of bulimia nervosa or anorexia nervosa.
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patients with type 2 diabetes may under-
report dietary intake. Studies that evalu-
ated whether type 1 diabetic patients
overreport or underreport dietary intake
associated with their weight status could
not be identiﬁed using our search
strategies.
Difﬁculty with diabetes self-manage-
mentcouldappeartobeDEB.Treatment-
related behaviors that may alter energy
intake include eating too much or too lit-
tle relative to glycemic status and insulin
dose, overconsumption of food to treat or
prevent hypoglycemia, and treatment of
presumed hypoglycemic symptoms with-
out checking blood glucose, resulting in
unnecessary caloric intake and the need
to take compensatory insulin (55). Inten-
tional insulin reduction or omission rela-
tive to food intake has been assessed in
various studies (2,21). However, the def-
initions of what constitutes insulin omis-
sion and reduction have not been
established in the context of diabetes
self-management behaviors, e.g., dose
adjustment.
Ongoing diabetes treatment exposes
patients to situations and emotions
known to be associated with the develop-
mentofDEB.Feelingsoflossofautonomy
and control are associated with the devel-
opmentofeatingdisordersinnondiabetic
individuals seeking weight loss (31). The
relationships are presumed to be similar
in patients with diabetes (53). Issues for
consideration include but are not limited
to: feelings of loss of control because of
required monitoring and reporting of
food intake, physical activity and blood
glucose, feeling loss of autonomy because
of parental/spousal/familial concern/
vigilance regarding health status (53),
increased perfectionism due to account-
ability to health care providers regarding
self-care behaviors and glycemic status
(8), lower self-esteem and body image
secondary to diagnosis and treatment
(56),andweightgainduetotheinitiation
of treatment (36).
Recent studies have examined rela-
tionships between personality character-
istics and DEB (57–59). Characteristics
studiedincludecopingstyles(60),unmit-
igated communion (putting others’ needs
and opinions before one’s own), harm
avoidance (avoidance of conﬂict), and
self-directedness (57). Women in partic-
ular are prone to unmitigated commun-
ion, harm avoidance, and lower self-
directedness, characteristics which are
hypothesized to place them at risk for
DEB.Ithasbeenspeculatedthatdifﬁculty
adjustingtothediabetesself-careregimen
and consequent weight gain may predis-
pose to adoption of maladaptive weight
management behavior to avoid disrup-
tion in relationships with care providers
and family members. Thus, certain per-
sonality characteristics in the context of
the self-management regimen may make
patients susceptible to DEB, independent
of other psychological, familial, or soci-
etal inﬂuences (11).
Evaluating new-onset type 1 diabetic
girls and boys, ages 8–13 years, from di-
agnosisupto14yearsofage,Pollocketal.
(12) concurrently evaluated DEB and
psychiatric symptomatology. Although
the authors found low rates of DSM-III
diagnosable eating disorders (3.8%),
“youths with eating problems were nine
times more likely to have had a psychiat-
ric disorder than the rest of the patients.”
A diagnosed eating disorder was distin-
guishedfromproblematiceatingbehavior
speciﬁctothediabetescareregimen.Reg-
imen-speciﬁc problems appeared to be
part of a constellation of pervasive non-
compliance associated with higher psy-
chiatric morbidity (12). The association
between psychiatric morbidity and diag-
nosable eating disorders (assessed using
the Structured Clinical Interview and the
Binge Eating Scale) was also studied in
type 2 diabetic patients. Overweight and
obese patients were found to have more
diagnosable eating disorders than
patients with a normal weight. Those
patients with eating disorders had signif-
icantly more anxiety disorders and
trended toward being more depressed
(4).Distress,particularlydepression,may
accompany onset of weight concerns as-
sociated with weight gain, consequent to
the difﬁculty of adhering to the diabetes
care regimen (8). Herpertz et al. (7) con-
ducted a cross-sectional study of the rela-
tionship between weight DEB, and
psychopathology in patients with type 2
diabetes,80%ofwhomcouldbeexpected
to be overweight. Weight had limited as-
sociation with weight-related distress but
no direct association with generalized
psychopathology.Eatingdisorderpathol-
ogy was, however, strongly associated
with depression and low self-esteem (7).
Studiesinpopulationsseekingweight
losshaveshownthattheonsetofDEBcan
precede or follow psychological distress
(58). The pathway whereby increased
weight precedes weight concerns is illus-
trated in a study of type 1 diabetic pa-
tients.BMIwastrackedconcurrentlywith
weight and shape concerns. As both male
and female patients became overweight,
DEB increased (23). Given the known co-
morbidity between increased psychological
distress and diabetes (61) and symptoms of
psychological maladjustment and DEB
(58), ﬁndings suggest that assessment of
psychological adjustment and regimen
compliance should be included when
symptoms of DEB are considered (12).
Treatment-based behavior that could
be identiﬁed as DEB might not be driven
by weight concerns. For example, devia-
tionfromtheprescribedinsulintreatment
regimen could be noncompliance or poor
adjustmenttotheillness.DEBcriteriaand
evaluationmethodsdevelopedinthegen-
eral population may need to be modiﬁed
to assess the range of self-treatment be-
haviors relevant to patients with diabetes
as well as concurrent psychological ad-
justment. Adding insulin omission as a
purging behavior has increased the po-
tential validity of screening measures and
DSM-IV-TR criteria, but other behaviors
central to diabetes treatment may also be
important. Taking into account treat-
ment-related and physiological phenom-
ena has the potential to improve the
accuracy of our assessments.
MEASUREMENT OF DEB
AND EATING DISORDERS—A
review of representative literature indicated
that questionnaires (9,34,37,49,62), inter-
views (13,19,28,29), and both methods
combined (4,12,15,19,26) have been
used to identify presence of DEB in stud-
ies of individuals with diabetes. All stud-
ies reviewed, except that by Markowitz
et al. (62), have used instruments and in-
terview techniques developed and/or stan-
dardized in the nondiabetic population to
establish the presence of DEB and eating
disorders. Questionnaires included but
arenotlimitedtotheEatingAttitudesTest
(EAT)-26 (40), Eating Disorders Inven-
tory (EDI)-2/3 (63), the Bulimia Test-
Revised (BULIT-R) (64), the Diagnostic
Survey for Eating Disorders (DSED) (49),
and the Binge Eating Scale (4). Informa-
tion is gathered via clinical interview for
the EDE (32) and the DSM-IV (33), and
each provides symptom criteria by which
tocategorizebehaviorsaseatingdisorders
and DEB. One study reported modiﬁca-
tion of the EDE for diabetes (15). The
DSED can be self-administered or con-
ducted by interview.
Questionnaires are generally ac-
knowledged to be appropriate for screen-
ing but not for diagnosis. This issue is
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by the wording of questions that ask
about prescribed diabetes management
behaviors. The BULIT-R DSED, and
EDI-3 were examined by the authors, a
psychologist diabetes educator, and a
psychologist with type 1 diabetes to iden-
tify questions that could be answered af-
ﬁrmatively in the context of diabetes self-
management behaviors. “Do you feel you
have control over the amount of food you
consume?” and “I eat a lot of food when
I’m not even hungry” are BULIT-R ques-
tions (used in studies by Affenito et al.
[17,18])thatdirectlyrelatetothediabetes
care regimen: the former by prescription
of dietary restraint and the latter by use of
exogenousinsulin.Alaterquestion,“Ifeel
that food controls my life,” could be en-
dorsed by any individual with diabetes.
Similarly, questions on the EDI-3 Drive
for Thinness Scale include, “I eat sweets
and carbohydrates without feeling ner-
vous,” and “I feel extremely guilty after
overeating.” Three of seven questions on
the Drive for Thinness subscale (used by
Engstrom et al. [19] to evaluate females,
and Svensson et al., [34] to evaluate
males) of the EDI regarding eating and
dietingthatcouldbeansweredinthecon-
text of having and treating diabetes were
identiﬁed. An additional three that ad-
dress the importance of weight status
could potentially be endorsed in the con-
text of health care provider recommenda-
tions. Using EDI-3 adult and adolescent
norms, endorsement of these questions
wouldlikelymeetcriteriaforthepresence
of subclinical DEB. Similarly, the DSED
(usedbyRydalletal.,[15]andJonesetal.,
[29]) asks about dieting behaviors that
couldbetreatmentbased.Thus,whenus-
ing questionnaires standardized in
healthy populations, scores may be ele-
vated in both type 1 and type 2 diabetic
patients due to items that reﬂect the dia-
betes self-care regimen. Conversely,
patients who are hesitant to reveal treat-
ment-related weight concerns to health
care providers may under-endorse items
that relate to their regimen. It has been
suggested that reﬁnement of questions
and criteria to include the effects of dia-
betes treatment is needed (49).
Intentional omission or reduction of
insulin dose for weight management pur-
poses is included in DSM-IV-TR criteria
(see Table 1) under the category of purg-
ingbehavior(27).However,thisbehavior
could be an aspect of generalized non-
compliance (12) or an attempt to reduce
hunger, improve feelings of satiety, or re-
duce the cycle of overeating consequent
to hypoglycemia. If the question is posed
whether insulin omission is intended to
control weight, the answer is frequently
afﬁrmative (6,8,10). Further reﬁnement
of the question querying the intent of and
motivation for insulin reduction in the
context of insulin dosing and hunger, as
well as weight concerns, would help to
establish whether the behavior could be
consideredadaptiveratherthanapurgeof
calories via glycosuria (10). The EDE asks
after behavioral intent, associated mood,
andthoughts.However,thecontributionof
the diabetes care regimen, diabetes self-
management education, and health care
provider directives regarding weight are
not routinely assessed to determine their
contribution to weight-driven behaviors or
concerns. Further reﬁnement and stan-
dardizationofquestionnairesandinterview
formatstodeterminethemotivationandin-
tent of behaviors in the diabetes population
willincreasediagnosticaccuracyinthecon-
text of diabetes.
The Diabetes Eating Problems Survey
(DEPS), created by Markowitz et al. (62),
includes questions regarding insulin ad-
justment speciﬁcally for the purposes of
weight reduction and couches questions
in terms of diabetes care. Issues related to
glycemic control and iatrogenic weight
gain are speciﬁcally identiﬁed and ques-
tioned. A questionnaire that asks about
satiety and fullness in the context of insu-
lin dosing, blood glucose levels, and eat-
ing in response to hypoglycemia is
currently being tested and standardized
(D.L.Y.-H. and C.L.D., personal commu-
nication). Validity studies that compare
the use of well-established DEB criteria,
interview formats, and instruments, ver-
sus diabetes-speciﬁc questionnaires and
interview formats assessing treatment
prescription, adjustment to illness, hun-
ger, satiety, and unintended outcomes of
treatment, are suggested to enhance the
accuracy of diagnosis and prevalence
of eating disorders and DEB in this
population.
SUMMARY
Limitations of current research
ﬁndings
Gaps in understanding the association of
DEB and diabetes include: lack of weight-
matched control subjects when compar-
ing the prevalence of eating disorders or
subclinical DEB; evaluation of the contri-
butions of an insulin dosing schedule and
overinsulinization (19), loss of satiety
mechanisms via hormonal dysregulation,
and dietary prescriptions as potential
causes perceived as loss of control over
food intake; the intent of behavior in
those seeking to prevent weight gain sec-
ondary to treatment; incomplete psycho-
logical characterization of samples,
including psychological constructs such
as loss of control, autonomy, and self-
efﬁcacy over blood glucose and weight;
the potential for misclassiﬁcation of be-
haviors and attitudes as reﬂecting DEB
when they possibly reﬂect skills and atti-
tudes learned as part of the diabetes care/
self-management regimen; and the need
for reﬁnement of existing measurement
tools and development of assessment
methodsthataddressdiabetes-speciﬁcat-
titudes, concerns, and behaviors that are
prescribed as part of treatment; as well as
physiological mechanisms that are be-
yond the control of the patient.
Most studied cohorts have consisted
of subjects that were white, heavier than
control samples, recruited from tertiary
care centers, and often monitored more
frequently and thoroughly than patients
receiving care in the community. Sample
selection bias may be operating to elimi-
nate well-controlled well-adjusted indi-
viduals from clinical studies, potentially
selecting individuals most vulnerable to
the development of DEB. No studies were
identiﬁed that monitored patients from
the time of diagnosis to establish the tem-
poral sequence of the onset of behavior
considered maladaptive and whether
weight gain occurs ﬁrst or the care regi-
men is manipulated to prevent weight
gain.Fewstudiescouldbefoundwherein
the comorbidity of depression and other
forms of psychological distress and DEB
were evaluated.
Directions for future research
Evaluation, characterization, and classiﬁ-
cationofDEBinindividualswithdiabetes
have clinical importance. However, clas-
siﬁcation of these behaviors is less clini-
cally informative if population-speciﬁc
criteriaandtaxonomyarenotestablished.
Further,focusingonidentiﬁedgapsinfu-
ture investigations of DEB in this popula-
tion could improve clinical care for this
serious comorbid condition. Studies that
chronicle the development of DEB pro-
spectively from diagnosis will allow us to
assess the contributions of the many fac-
tors that predispose individuals to the de-
velopmentofDEB,potentiallyidentifying
approaches to diabetes treatment with a
lower risk of iatrogenic complications. It
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tify those individuals who are at risk for
this comorbid condition in association
with and independent of the burden of
diabetes care. In order to distinguish
whether insulin reduction or omission is
maladaptive, evaluation of the intent and
context of this behavior is needed. Is it a
means to regain control over excessive
eatingbyusingself-managementskillsor,
in contrast, is it intended as a short-cut
weight management strategy (purging via
glycosuria)? Physiological mechanisms
such as an insulin dose in excess of phys-
iologicalrequirement,hypoglycemia,and
a hormonally driven imbalance in hun-
ger, food intake, and experience of satiety
appeartobecriticalfactorsinestablishing
diabetes-speciﬁccriteriathatdiscriminate
between maladaptive manipulations of
the diabetes care regimen to control
weight and potentially adaptive regimen
modiﬁcations.Studiesareneededthatad-
dress these distinctions.
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